Skip to content

Clinical trials

Parkinson Disease trials in Switzerland with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Not applicable Country / region: Switzerland Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20143
20165
20172
20182
20205
20218
20222
20234
20247
20255
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting20
Completed16
Unknown status7
Terminated4
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Insel Gruppe AG, University Hospital Bern7
University of Zurich6
Luzerner Kantonsspital4
Ecole Polytechnique Fédérale de Lausanne3
Jocelyne Bloch3
University Hospital, Basel, Switzerland3
Aleva Neurotherapeutics SA2
Christian Baumann2
Klinik Valens2
Swiss Federal Institute of Technology2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease49
Nerve Degeneration5
Cognitive Dysfunction4
Essential Tremor4
Neurodegenerative Diseases3
Stroke3
Basal Ganglia Diseases2
Central Nervous System Diseases2
Disruptive, Impulse Control, and Conduct Disorders2
Dysarthria2

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.